https://www.acplgroupindia.in
91

POLICY ON NEW DRUG APPLICATION: 1. The content of New Drug Application (NDA) should be des...

View more

POLICY ON NEW DRUG APPLICATION: 1. The content of New Drug Application (NDA) should be des...

View more

3. To enhance the communication aspects, CDSCO should ensure that the industry representat...

View more

INDUSTRY AND CDSCO COMMUNICATION 1. CDSCO needs to work collaboratively and cooperatively ...

View more

POLICY ON POST-APPROVAL STUDIES 1. Post-approval studies may be required to provide additi...

View more

3. As per the rules, for manufacture or import of new drugs, the manufacturers/ importer a...

View more

INTRODUCTION 1. A number of communicable as well as non-communicable diseases place heavy ...

View more

Such discussion to help the reviewers becomes acquainted with the information to be includ...

View more

POLICY ON NEW DRUG APPLICATION: 1. The content of New Drug Application (NDA) should be des...

View more

Subscribe for latest offers and updates.

we hate spam too